Skip to main content

BIOTRICITY INC.

For the period ended Mar 31, 2025. Filed Jul 15, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Jul 15, 2025

BTCY$0.14+7.5%Stored close · as of Jul 8, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

Pursuant to the requirements of the Section 13 or 15 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the day of July 15, 2025.

BIOTRICITY INC.
By:/s/ Waqaas Al-Siddiq
Waqaas Al-Siddiq
Chief Executive Officer and President

In accordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Waqaas Al-SiddiqChairman, President and Chief Executive Officer (principal executive officer)July 15, 2025
Waqaas Al-Siddiq
/s/ John AyanoglouChief Financial Officer (principal financial and accounting officer)July 15, 2025
John Ayanoglou
/s/ David A. RosaDirectorJuly 15, 2025
David A. Rosa
/s/ Jainal BhuiyanDirectorJuly 15, 2025
Jainal Bhuiyan
/s/ Ronald McClurgDirectorJuly 15, 2025
Ronald McClurg

Biotricity Inc.

For the years ended March 31, 2025 and 2024

Table of Contents

Report of Independent Registered Public Accounting Firm (PCAOB ID: 5828)F-1
Consolidated Financial Statements for the years ended March 31, 2025 and 2024:
Consolidated Balance SheetsF-3
Consolidated Statements of Operations and Comprehensive LossF-4
Consolidated Statements of Mezzanine Equity and Stockholders’ DeficiencyF-5
Consolidated Statements of Cash FlowsF-6
Notes to Consolidated Financial StatementsF-7 - F-40
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.